[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Registration::
Contact us::
Site Facilities::
Ethics::
peer-review::
Indexing::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
Journal DOI

AWT IMAGE

..
Copyright Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 
This Journal is licensed under a Creative Commons Attribution-NonCommercial 4.0
..
:: Volume 10, Issue 1 (4-2008) ::
J Babol Univ Med Sci. 2008; Volume 10 Back to browse issues page
COMPARISON OF SERUM LEVELS OF CD26 AND CD30 IN CHRONIC RENAL FAILURE AND HEMODIALYTIC PATIENTS
AR Rafiei, * , A Makhlough , S Hashemi Nasab , MR Mahdavi , AM Mirabi
Abstract:   (6461 Views)
BACKGROUND AND OBJECTIVE: Various abnormalities of the immune system have been demonstrated in patients on hemodialysis. Imbalances in Th1 and Th2 responses have an important role in these complications. These cells produce predominantly some cytokine profiles and also express preferentially co-stimulatory CD26 and CD30 molecules. The aim of the present study was to determine the levels of soluble CD26 and CD30 co-stimulatory molecules in sera of chronic renal failure (CRF) and hemodialytic patients (HD).
METHODS: This case-control study was performed on 60 CRF patients (30 patients with CRF and 30 end-stage renal diseases under hemodialysis) and 60 healthy individuals. Renal function was evaluated by measuring serum levels of creatinine, albumin and urea. The serum levels of soluble CD26 and CD30 were determined by a sandwich enzyme-linked immunosorbent assay.
FINDINGS: The serum levels of CD26 in the HD, CRF patients, and healthy controls were 275.4±125.6, 402.9± 103.1, and 389.2±117 ng/ml, respectively. The levels of CD26 was significantly decreased in the HD group compared to the CRF and control groups (p=0.002). On the other hand, the serum levels of CD30 in the HD, CRF patients, and healthy controls were 45.3±13.7, 38.9±14.5, 20.7±10.5 U/ml, respectively. The CD30 levels were significantly higher in HD and CRF patients than controls (p<0.0001). There was no significant difference between HD and CRF groups (p=0.05).
CONCLUSION: High serum levels of CD30 in line with low expression of CD26 indicate a Th2 polarization in immune responses of HD patients. It is possible that this Th2- dominated immune response may contribute to the abnormality of the immune system in HD patients.
Keywords: Chronic renal failure, Heamodialysis, CD26, CD30
Full-Text [PDF 334 kb]   (2626 Downloads)    
Type of Study: Research | Subject: Biochemical
Accepted: 2014/06/2 | Published: 2014/06/2


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Rafiei, A, Makhlough A, Hashemi Nasab S, Mahdavi M, Mirabi A. COMPARISON OF SERUM LEVELS OF CD26 AND CD30 IN CHRONIC RENAL FAILURE AND HEMODIALYTIC PATIENTS. J Babol Univ Med Sci 2008; 10 (1) :20-27
URL: http://jbums.org/article-1-2479-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 10, Issue 1 (4-2008) Back to browse issues page
مجله علمی دانشگاه علوم پزشکی بابل Journal of Babol University of Medical Sciences

The Journal of Babol University of Medical Sciences is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Persian site map - English site map - Created in 0.05 seconds with 43 queries by YEKTAWEB 4645